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Abstract
Since the concentration of free iron in the human host is low, efficient iron-acquisition mechanisms constitute important
virulence factors for pathogenic bacteria. In Gram-negative bacteria, TonB-dependent outer membrane receptors are
implicated in iron acquisition. It is far less clear how other metals that are also scarce in the human host are transported
across the bacterial outer membrane. With the aim of identifying novel vaccine candidates, we characterized in this study a
hitherto unknown receptor in Neisseria meningitidis. We demonstrate that this receptor, designated ZnuD, is produced
under zinc limitation and that it is involved in the uptake of zinc. Upon immunization of mice, it was capable of inducing
bactericidal antibodies and we could detect ZnuD-specific antibodies in human convalescent patient sera. ZnuD is highly
conserved among N. meningitidis isolates and homologues of the protein are found in many other Gram-negative
pathogens, particularly in those residing in the respiratory tract. We conclude that ZnuD constitutes a promising candidate
for the development of a vaccine against meningococcal disease for which no effective universal vaccine is available.
Furthermore, the results suggest that receptor-mediated zinc uptake represents a novel virulence mechanism that is
particularly important for bacterial survival in the respiratory tract.
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Introduction
The cell envelope of Gram-negative bacteria consists of two
membranes, the inner and the outer membrane, which are
separated by the periplasm containing the peptidoglycan layer.
The outer membrane forms a barrier for harmful compounds from
the environment. Most nutrients can pass the outer membrane by
passive diffusion via abundant channel-forming outer membrane
proteins, collectively called porins. However, diffusion is not an
option when the extracellular concentration of a nutrient is low.
This is usually the case, for example, with iron. Pathogens are
confronted with low concentrations of free iron within the human
host, where iron is bound by iron-transport and -storage proteins,
such as lactoferrin and transferrin. Hence, efficient iron acquisition
mechanisms constitute important virulence factors and have been
studied extensively in many pathogens [1,2].
When grown under iron-limiting conditions, Gram-negative
bacteria induce the synthesis of outer membrane proteins that
function as receptors for the iron-binding proteins of the host, for
heme, or for siderophores, which are small iron-chelating
compounds produced and secreted by the bacteria under iron
limitation. The resolved crystal structures of such receptors
revealed 22-stranded b-barrels, which do not form open channels
but are closed by an N-terminal plug domain [3]. After binding of
the ligand to the receptor, the subsequent uptake of the nutrient is
an active process that requires the energy of the proton gradient
across the inner membrane, which is coupled to the receptors in
the outer membrane via a complex of three proteins, the TonB
complex [4,5].
While iron-acquisition mechanisms have been studied exten-
sively in many Gram-negative bacteria, little is known yet about
the transport of other essential heavy metals, such as zinc and
manganese, across the bacterial outer membrane. The concen-
trations of also these trace elements are low in the human host,
which responds to infections, amongst others, by the production of
metallothioneins and calprotectin, thereby reducing the availabil-
ity of metals to the invading pathogens [6,7]. Therefore, Gram-
negative pathogens likely possess effective mechanisms for the
acquisition of these metals, which may or may not resemble the
iron-acquisition systems.
Neisseria meningitidis is an obligate human pathogen that can
colonize the nasopharyngeal mucosa asymptomatically. Occasion-
ally the bacterium enters the bloodstream and can cause sepsis and
meningitis with a high mortality rate [8]. While vaccines based on
the capsular polysaccharides are available for most pathogenic
serogroups of N. meningitidis, a vaccine against serogroup B
meningococci is lacking. The polysaccharide capsule of the
serogroup B strains is poorly immunogenic due to its resemblance
to human glycoproteins [9]. Thus, subcapsular antigens are being
studied as alternative vaccine components; however, these studies
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membrane proteins. Therefore, attention has shifted to minor
antigens, including the TonB-dependent receptors.
When grown under iron limitation, N. meningitidis produces
TonB-dependent receptors for lactoferrin [10], transferrin [11],
hemoglobin [12,13] and enterobactin [14], all involved in the
uptake of iron. Based on homology searches, Turner et al.
identified seven additional genes for putative TonB-dependent
family (Tdf) members in the available genome sequences of three
Neisserial strains [15]. Interestingly, the expression of some of
these tdf genes appeared unaffected by iron availability in various
microarray studies [16,17], indicating that their products might be
implicated in the transport of metals other than iron. Here we
studied the regulation of the synthesis, the function, and the
vaccine potential of one of these receptors and show that this
receptor is involved in the uptake of zinc. We therefore named this
protein, encoded by locus NMB0964 in the genome sequence of
strain MC58 [18], ZnuD for zinc uptake component D.
Results
Regulation of znuD expression by zinc
To study the expression of znuD in N. meningitidis, we raised a
polyclonal antiserum against the protein produced in Escherichia coli
in inclusion bodies. While the antiserum did recognize the protein
produced in E. coli, we could never detect ZnuD when whole cell
lysates of N. meningitidis strain HB-1, an unencapsulated derivate of
serogroup B strain H44/76, were analyzed on Western blots after
growth in tryptic soy broth (TSB) (Figure 1A, lane 1). However,
when the bacteria were grown in chemically defined RPMI
medium, ZnuD was detectable in the lysates (Figure 1A, lane 2).
The specificity of the signal detected was demonstrated by its
absence in a constructed znuD knockout strain (Figure 1A, lane 3).
We noticed that the addition of even small amounts of TSB to
RPMI negatively affected ZnuD synthesis (Figure 1B), suggesting
that TSB contains a compound that represses the transcription of
znuD. RPMI does not contain a source of trace metals. Since Tdf
members are usually regulated by iron availability, we first tested
whether znuD expression could be repressed by adding an iron
source; however, addition of even up to 10 mM FeCl3 to the
medium did not affect ZnuD production (Figure 1C). Next, we
decided to test whether a cocktail of trace metals, consisting of
340 nM ZnSO4, 160 nM Na2MoO4, 800 nM MnCl2,8 0 n M
CoCl2 and 80 nM CuSO4 (final concentrations), could repress
znuD expression, which indeed appeared to be the case. Then, all
these metal salts were tested separately, and specifically zinc, even
at sub-mM concentrations, appeared to repress znuD expression
(Figure 1D). Since standard RPMI is not supplemented with a
specific zinc source, the available zinc required for bacterial
growth is presumably derived from the water or the salts used to
constitute the medium. The zinc concentration in the standard
RPMI medium measured by inductively coupled plasma mass
spectrometry (ICP-MS) was found to be ,110 parts per billion
(,1.69 mM), which is apparently sufficient for growth of the
bacteria but insufficient for repression of znuD expression.
The zinc regulation of znuD expression was further evaluated by
supplementing the RPMI medium with the specific zinc chelator
N,N,N9,N9-Tetrakis-(2-pyridylmethyl)-ethylenediamine (TPEN),
which resulted in a dose-dependent increase in ZnuD synthesis
(Figure 1E). Concentrations of TPEN above 1 mM totally inhibited
bacterial growth presumably due to total depletion of zinc from
the medium. The growth defect induced by TPEN could be
restored by the addition of zinc (not shown). The zinc-dependent
regulation of znuD expression was further confirmed by real-time
quantitative PCR (RT-qPCR) using total RNA obtained from
cultures grown in RPMI supplemented or not with either 0.5 mM
ZnSO4 or 0.5 mM TPEN. The data showed a 13.861.3-fold
repression in the presence of zinc and a 3.861.2-fold induction in
the presence of TPEN. The fold difference between added TPEN
and zinc was 52.6.
Role of the transcriptional regulator Zur in znuD
expression
In E. coli, the zinc uptake regulator Zur has been shown to
regulate the expression of the znuACB operon. The genes of this
operon encode the periplasmic substrate-binding protein, the
ATPase and the integral inner membrane component, respective-
ly, of an ABC transporter required for the transport of zinc from
the periplasm into the cytoplasm [19]. In the presence of zinc, Zur
binds a Zur-binding element (consensus sequence GAAATGT-
TATANTATAACATTTC) in the promoter of the znuACB
operon and thereby blocks transcription [20].
In the genome sequence of N. meningitidis strain MC58, we
identified homologues of the E. coli zur gene, i.e. NMB1266, and of
a putative znuCBA operon, i.e. NMB0588, NMB0587, and
NMB0586. In addition, we found sequences resembling the E.
coli Zur binding sequence in the regions upstream of the znuD
(GtAATGTTATATaATAACAaact) and znuC (cAAAcGTTATA-
CagTAtCATaTC) (identical nucleotides to the E. coli consensus
are in capital case). To confirm the involvement of Zur in the
regulation of znuD expression, we generated a zur mutant of strain
HB-1, which, indeed, produced ZnuD constitutively (Figure 1F).
Also, RT-qPCR demonstrated the involvement of Zur in the
expression of znuA and znuD,a sznuA and znuD expression levels
increased 5.060.8-fold and 34.060.8-fold, respectively, in the zur
mutant compared to its parent strain both grown in RPMI
supplemented with 0.5 mM ZnSO4.
ZnuD facilitates zinc acquisition
Since the expression of znuD is regulated by the availability of
zinc, it seemed likely that ZnuD acts as a receptor for zinc or a
Author Summary
The outer membrane protects Gram-negative bacteria
against harmful compounds from the environment.
Nutrients usually pass this barrier by passive diffusion via
pore-forming proteins. However, nutrients that are scarce
in the environment are taken up via an active, receptor-
mediated process. The vast majority of Gram-negative
bacterial receptors described to date are involved in iron
acquisition. Since free iron is scarce in the human host,
these receptors constitute important virulence factors. In a
search for putative vaccine components, we have charac-
terized here a new receptor of Neisseria meningitidis,a
resident of the nasopharynx that occasionally causes sepsis
and meningitis. We show that expression of this receptor is
induced under zinc limitation and that the protein is
involved in the uptake of zinc. Homologues of this protein
are present in many other Gram-negative pathogens,
particularly in those residing in the respiratory tract,
suggesting that receptor-mediated zinc acquisition is
important for bacteria residing in this niche. We also
found that the protein is highly conserved among N.
meningitidis isolates and that it induces bactericidal
antibodies upon immunization of mice. Therefore, the
protein appears an excellent candidate for the develop-
ment of a vaccine against N. meningitidis, for which no
universal vaccine is available yet.
Zinc-Regulated Neisserial Vaccine Candidate
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sequence and constructed a topology model of the barrel domain
of ZnuD using the PROFtmb program at www.rostlab.org [21]
and a 3D structural model of the plug domain based on known
structures of TonB-dependent receptors using 3D-jigsaw [22]
(Figure 2). ZnuD contains two cysteine residues in the putative
extracellular loop L3. When these cysteines form a disulfide bond,
they bring two stretches of amino acid residues, both rich in
histidine and aspartic acid residues, in close proximity (Figure 2).
The resulting His- and Asp-rich domain could be of functional
importance, since also in the periplasmic zinc-binding protein
ZnuA of E. coli, a stretch of His and Asp residues is involved in
binding its ligand [23]. Thus, we considered the possibility that
ZnuD binds free zinc and transports it into the periplasm. To test
this hypothesis, we first determined whether ZnuD could bind
zinc. To this end, N. meningitidis strain CE1523, an H44/76
derivative that lacks porin PorA and the polysaccharide capsule,
was transformed with a plasmid carrying znuD under the control of
an isopropyl-b-D-1-thiogalactopyranoside (IPTG)-inducible pro-
moter. The resultant strain was grown with and without IPTG,
and outer membrane vesicles (OMVs) were isolated (Figure 3A,
left panel) and compared for their capacity to compete with 4-(2-
pyridylazo)resorcinol (PAR) for binding zinc. In the presence of
OMVs containing ZnuD, ,40% more free PAR was measured
than in the presence of OMVs lacking ZnuD, indicating that
ZnuD is capable of binding zinc (Figure 3B). To demonstrate the
involvement of ZnuD in binding zinc directly, ZnuD was
produced in E. coli in inclusion bodies, which were isolated, and
the protein was folded in vitro into its native conformation. Like
many other outer membrane proteins [24], ZnuD displays heat
Figure 1. Regulation of znuD gene expression. Western blots of cell lysates using rabbit antiserum against ZnuD. (A) HB-1 grown in TSB (lane 1),
RPMI (lane 2) and the znuD knockout strain grown in RPMI (lane 3). (B) HB-1 grown in RPMI supplemented with 0, 2, 4, 6 and 8% TSB (lanes 1–5,
respectively). (C) HB-1 grown in RPMI supplemented with 0, 2, 5, and 10 mM FeCl3 (lanes 1–4, respectively). (D) HB-1 grown in RPMI supplemented
with 0, 0.5 or 1 mM ZnSO4 (lanes 1–3, respectively). (E) HB-1 grown in RPMI supplemented with 0, 0.1, 0.5 or 1 mM TPEN (lanes 1–4, respectively). (F)
HB-1 (lanes 1–3) and the zur mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 0.6 mM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6).
doi:10.1371/journal.ppat.1000969.g001
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mobility than the correctly folded form, a property that was used
to monitor proper folding (Figure 3A, right panel). The native
protein was then tested alongside the unfolded protein in the PAR
competition assay. The folded protein indeed competed with PAR
for zinc while the unfolded protein did not (Figure 3B) showing the
specificity of the reaction.
If ZnuD is indeed involved in the uptake of free zinc, one would
expect a higher external zinc concentration to be required to
repress expression of znu genes in the znuD mutant than in the
wild-type strain. To test this idea, the znuD mutant and its parent
strain were grown in RPMI medium supplemented with 0.5 mM
ZnSO4, which largely, but not completely represses znuD
expression in the wild-type strain (Figure 1D). The relative levels
of znuD and znuA mRNA were then measured by RT-qPCR. Of
note, the znuD mutant still contains the first 437 nucleotides of the
znuD gene and 100 nucleotides thereof were used for the detection
of znuD gene expression. In the znuD mutant, there was 18.661.1-
fold more znuD and 7.461.1-fold more znuA expressed compared
to the parent strain, showing that indeed the intracellular zinc
concentration in the znuD mutant is lower than that in the parent
strain under the applied growth conditions. Also, Western-blot
analysis showed that a znuA knockout strain produced high levels
of ZnuD in the presence of zinc, confirming that ZnuA is required
to sustain sufficient zinc levels in the cell (Figure 3C).
Finally, we tested whether expression of znuD offers any growth
advantage under zinc limitation. To deplete the internal zinc
stores, the bacteria were first grown overnight on RPMI plates,
supplemented with 100 mM ferric chloride to prevent iron
depletion. Subsequently, they were inoculated in RPMI supple-
mented or not with TPEN. In the absence of TPEN, growth of the
bacteria was only marginally affected by the absence of ZnuD, but,
in contrast to the parental strain, the znuD mutant failed to grow
when 0.3 mM TPEN was added to the medium (Figure 3D). These
Figure 2. Topology model of ZnuD. The 22 b-strands are colored light grey, the 11 extracellular loops are white and the periplasmic turns are
black. The histidine/aspartic acid stretches are boxed. The plug domain was modeled based on known Tdf structures. The amino acid sequence of
loop 3 is shown with the cysteines in bold and the His/Asp-rich stretches underlined. Numbers indicate amino acid positions in the sequence of
mature ZnuD.
doi:10.1371/journal.ppat.1000969.g002
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when the available zinc is limiting.
We also assessed whether TonB is required for ZnuD-mediated
zinc acquisition. In growth experiments, a tonB knockout strain grew
less well than the parent but better than the znuD mutant in the
presenceofTPEN(Figure3D).However,inRT-qPCRexperiments,
we did not observe increased expression of znuAorznuDaftergrowth
of the tonB mutant inRPMIsupplemented with 0.5 mMZ n S O 4 and,
consistently, we could not detect more ZnuD under these conditions
by Western-blot analysis (Figure 3E). Together, these results suggest
that TonB facilitates the uptake of free zinc through ZnuD, but that
uptake can take place also independently of TonB.
Vaccine potential of ZnuD
To investigate whether ZnuD could be a candidate component
for a universal N. meningitidis vaccine, we first studied its
Figure 3. Zinc binding and transport by ZnuD. (A) Coomassie-stained SDS-PAGE gels showing the protein content of the OMVs (left) and
purified ZnuD preparation (right) used in the PAR-binding assay. OMVs were isolated from strain CE1523 carrying pEN11-znuD that was either
induced or not with IPTG for znuD expression as indicated. Purified ZnuD from inclusion bodies (IB ZnuD) was refolded in vitro (Folded ZnuD). The
folded ZnuD sample was not heated before SDS-PAGE and the positions of folded and unfolded ZnuD are indicated. (B) Binding of zinc to OMVs
either or not containing ZnuD and to purified ZnuD that was either folded or not was measured in a PAR competition assay. Shown are the
normalized values of the absorption at 500 nm of five independent measurements. (C) Western blot of whole cell lysates of strain HB-1 (lanes 1–3)
and the znuA mutant (lanes 4–6) grown in RPMI (lanes 1 and 4), RPMI with 500 nM ZnSO4 (lanes 2 and 5) or TSB (lanes 3 and 6). (D) Representative
growth curves (n=5) of the znuD and tonB knockout strains and their parent strain in response to zinc limitation. Cultures contained either 0 or
0.3 mM TPEN. (E) Western blot of whole cell lysates of strain HB-1 (lanes 1–2) and the tonB mutant (lanes 3–4) grown in RPMI (lanes 1 and 3) or RPMI
with 500 nM ZnSO4 (lanes 2 and 4).
doi:10.1371/journal.ppat.1000969.g003
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were found in all the available N. meningitidis genome sequences
and they showed a strikingly high 97–99% amino acid identity in
the mature part of the protein (Figure S1, Supporting Informa-
tion). The sequence differences are scattered throughout the
protein and are not clustered in predicted extracellular loop
regions, which are often antigenically variable in Neisseria outer
membrane proteins. We subsequently analyzed the presence of
ZnuD in a panel of 32 different N. meningitidis isolates from
different serogroups and different clonal lineages. The strains were
grown in RPMI medium supplemented or not with 0.5 mM
ZnSO4, and whole cell lysates were analyzed by Western blotting
with the antiserum raised against ZnuD of strain H44/76. ZnuD
was detected in all strains tested and in all cases znuD expression
was repressed in the presence of zinc, albeit to different extents
(Figure 4A).
To investigate whether ZnuD is expressed in the human host,
we tested sera from convalescent patients, healthy carriers and
non-carriers [10,25] for the presence of antibodies that recognize
ZnuD on Western blots. The reactivity of the sera was tested
against both the denatured and the refolded form of the ZnuD
protein (Figure 3A, right panel). We could detect ZnuD-specific
antibodies in sera from most convalescent patients and healthy
carriers tested (examples are shown in Figure 4B), although also
some sera were negative (e.g. serum 262658 in Figure 4B). The
positive sera reacted with both the denatured protein and the
protein folded in vitro into its native conformation although the
relative intensity of the reaction with the two forms of the protein
varied (Figure 4B). No ZnuD-specific antibodies were detected in
the sera from non-carriers (results not shown).
Next, we immunized 10 mice with OMVs from a strain
overexpressing this protein (Figure 3A) and tested the resultant
pooled sera for the presence of bactericidal antibodies. Routinely,
we perform serum bactericidal assays on bacteria grown in TSB
medium; however, under these conditions znuD is not expressed.
Therefore, we tested the sera for bactericidal activity on a
derivative of strain H44/76 that expressed znuD from an IPTG-
inducible promoter and compared cultures grown with and
without 1 mM IPTG. The bactericidal titers of the pooled sera
were ,1:100 against bacteria not producing ZnuD, but 1:1042
against bacteria producing ZnuD. Titers in pre-immune sera were
,1:100 independent of whether ZnuD was produced or not.
These data clearly show that ZnuD is able to elicit bactericidal
antibodies. Thus, since ZnuD is highly conserved among N.
meningitidis isolates and elicits bactericidal antibodies, it might be an
attractive vaccine component.
ZnuD homologs in other bacteria
Genes encoding the high-affinity ZnuABC uptake system for
zinc have been identified in many bacteria, but the involvement of
an outer membrane receptor in zinc acquisition has not been
described so far. To investigate whether an outer membrane
receptor might be more generally associated with zinc acquisition,
we searched for ZnuD homologs in other pathogenic bacteria by
performing BLAST searches at NCBI. ZnuD homologs with high
sequence similarity (,96% identity) were found in Neisseria
gonorrhoeae strain FA1090 (locus NGO_1205) and other N.
gonorrhoeae strains. Homologs of ZnuD were also found in other
pathogenic bacteria, including Moraxella catarrhalis, Haemophilus
parasuis, Mannheimia haemolytica, Acinetobacter baumannii, Pasteurella
multocida, Bordetella pertussis, and Actinobacillus pleuropneumoniae
(Table 1). All these ZnuD homologs contain the His- and Asp-
rich regions suspected to be involved in zinc binding (Figure S2,
Supporting Information). Interestingly, in B. pertussis the znuD
homolog is located adjacent to a gene cluster containing homologs
of the znuABC and zur genes, again indicating a functional
relationship between these genes. Thus, it appears that outer
membrane receptor-mediated zinc acquisition is not specific for N.
meningitidis, but is more common among pathogenic Gram-
negative bacteria.
Discussion
The Gram-negative bacterial outer membrane forms a
protective barrier that protects the bacteria against harmful
compounds from the environment, including antibiotics, deter-
gents and digestive enzymes. By the presence of porins, it functions
as a molecular sieve that allows for the passage of hydrophilic
solutes with molecular weights up to ,600 Da by passive
diffusion. Most nutrients can pass the outer membrane via the
porins. However, passive diffusion is effective only when the
external solute concentration is high. The bacteria may also
require nutrients that are present in the environment in low
concentrations or that are too large to pass through the porins. For
such cases, the bacteria have developed active transport systems in
the outer membrane that depend on a Tdf receptor with high
affinity for its ligand and on the TonB complex that delivers
the electrochemical energy of the proton gradient across the
inner membrane to the transport process across the outer
membrane [3–5].
Most Tdf members studied to date are involved in iron
acquisition [1,2], a notable exception being BtuB protein of E. coli,
which mediates the uptake of vitamin B12 [26]. Since the free iron
concentration in the human host is too low to support bacterial
growth, efficient iron-acquisition systems constitute important
virulence factors of pathogenic bacteria. These bacteria usually
can use multiple iron sources including siderophores produced by
themselves or by other micro-organisms, heme, and iron-transport
and -storage proteins of the host. For each iron source, the
bacteria require a specific receptor. However, based on the
available genome sequences, the number of Tdf receptors in a
bacterium can be very high. For example, Pseudomonas aeruginosa
may contain up to 37 different Tdf receptors [27] suggesting that
at least some of these receptors might have functions other than
iron or vitamin B12 transport. Indeed, in Caulobacter crescentus, Tdf
receptors have been described that are involved in the uptake of
carbon sources [28,29]. C. crescentus thrives in nutrient-poor fresh-
water lakes where receptor-mediated active transport across the
outer membrane offers a solution to acquire sufficient nutrients.
Also, very recently, a receptor for nickel has been described in
Helicobacter mustelae [30].
Here, we describe for the first time a Tdf receptor involved in
the acquisition of zinc. Like the levels of free iron in the human
host, those of free zinc are most likely too low to sustain bacterial
growth. For example, although the total concentration of zinc in
human serum is approximately 13 mM, the vast majority of it is
bound by serum proteins such as albumin [31]. In addition, the
human host responds to infections by the production of
metallothioneins and calprotectin, which reduce the availability
of zinc and other metals to the invading pathogens [6,7]. The
high-affinity ZnuABC system for the uptake of zinc across the
inner membrane has been identified in many bacteria, including
Neisseria gonorrhoeae [32] and Salmonella enterica [33] where it was
shown to be associated with virulence [33,34]. Likewise, the outer
membrane receptor for zinc acquisition identified here, ZnuD, is
presumably important for virulence, which, however, is difficult to
establish in N. meningitidis, for which a suitable animal model is
lacking.
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expression facilitates the uptake of free zinc at low zinc
concentrations. Although ZnuD is a Tdf member, TonB appeared
not to be required for ZnuD-mediated zinc uptake. However, it is
entirely possible that ZnuD, besides its function as a receptor for
free zinc, could additionally recognize a complexed form of zinc,
which may be available in the respiratory tract, in serum and/or in
cerebral fluid. If that is the case, we expect that the TonB system
will be needed for the acquisition of zinc from such ligand.
Previously, znuD expression was reported to be induced in the
presence of active complement [35]. In that microarray study, the
expression profiles were compared of N. meningitidis strain Z5463
grown in the presence of serum that was either inactivated or not
by heat. Expression of znuD (locus tag NMA1161) was found 23-
fold de-repressed in the presence of the untreated serum. A
possible explanation for this observation is the presence in serum
of albumin, which is known to chelate zinc [31]. Heat treatment of
serum will probably release zinc from albumin, which could
Figure 4. ZnuD synthesis in meningococcal isolates and in vivo. (A) Western blots of cell lysates of the indicated strains grown in RPMI with
or without added zinc.
a Clonal group designations taken from [40]; –, the strain was typed by Multi-Locus Enzyme Electrophoresis but could not be
assigned to a specific clone; ND, not determined. (B) Reaction of human sera with ZnuD on Western blots. The blots contained both native and
denatured ZnuD. The specific patient sera used are indicated above the lanes and have been described previously [10,25]. Also an example of a non-
reactive patient serum is shown at the right.
doi:10.1371/journal.ppat.1000969.g004
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bacteria exposed to untreated serum where zinc is chelated.
Consistent with this explanation is the observation in the same
microarray study that also the genes with locus tags NMA1137
and NMA1138, which encode paralogs of the ribosomal proteins
L36 and L31 that are induced in many bacterial species under zinc
limitation [36], were strongly induced in the presence of the
untreated serum [35].
N. meningitidis normally lives as a commensal on the mucosal
surfaces in the upper respiratory tract. Zinc is found on mucosal
surfaces, but the total zinc concentrations or the amount of free
zinc present are not known. However, it is intriguing that ZnuD
homologs were particularly found in bacterial species residing in
the respiratory tract of humans and animals. Probably, the
unbound zinc concentration in the mucosal layers of the
respiratory tract is too low to allow sufficient passive diffusion
through the porins and, therefore, ZnuD may become essential for
bacterial growth and survival particularly in this niche. This
hypothesis is strengthened by the detection of specific antibodies
against ZnuD in the serum from healthy carriers, which indicates
that ZnuD is expressed where the bacteria normally reside, the
nasopharynx.
As a pathogen, N. meningitidis can enter the bloodstream and
cause sepsis and meningitis with a high mortality rate. A vaccine
against serogroup B meningococci is not available, because the
corresponding capsular polysaccharide is poorly immunogenic.
Outer membrane proteins are being studied as alternative vaccine
components, but these studies are frustrated by the high antigenic
variability of the major outer membrane proteins. Since ZnuD is
highly conserved among N. meningitidis isolates and elicits
bactericidal antibodies, it might be an attractive vaccine
component, particularly in combination with other minor outer
membrane proteins due to the synergistic bactericidal activity of
antibodies against such antigens [37].
Materials and Methods
Bacterial strains and growth conditions
Except when indicated otherwise, experiments were performed
with the unencapsulated N. meningitidis strain HB-1 [38] and
mutants thereof. Strain CE1532 was constructed from strain
CE2001, a porA-deficient derivative of H44/76 [39], by inactivat-
ing the capsule locus similarly as described for HB-1 [38]. N.
meningitidis was grown on GC agar (Oxoid) plates containing Vitox
(Oxoid) and antibiotics when appropriate (kanamycin, 100 mg/ml;
chloramphenicol, 10 mg/ml) in candle jars at 37uC. Liquid
cultures were grown in TSB (Difco) or in RPMI (Sigma) at
37uC with shaking. E. coli strains DH5a and TOP10F9 (Invitrogen)
were used for routine cloning. E. coli was propagated on Luria-
Bertani (LB) medium supplemented when appropriate with
100 mg/ml ampicillin, 50 mg/ml kanamycin, or 25 mg/ml chlor-
amphenicol.
Construction of plasmids and mutants
Primers used are listed in Table S1 (Supporting Information).
The znuD gene without the signal sequence-encoding part was
amplified from chromosomal DNA of strain H44/76 by PCR
using the primers 0964-F and 0964-R and cloned into pCRII-
TOPO (Invitrogen), generating pCRII-znuD. From there, it was
subcloned into pET11a (Novagen) using NdeI/BamHI restriction,
resulting in plasmid pET11a-znuD.
To obtain a znuD deletion construct, a kanamycin-resistance
gene cassette was amplified by PCR with the primers Kan-R and
Kan-F from pCR2.1-Kan/Dus [40] and cloned after MluI and
BsrGI digestion into pCRII-znuD digested with the same enzymes.
In the resulting construct, pCRII-znuD::kan, the kanamycin-
resistance cassette substitutes for the region between base pairs
437 and 1344 of znuD. The znuD::kan construct was amplified with
primers 0964-R and 0964-F and used to transform strain HB-1 to
generate a znuD mutant.
For regulated expression of znuD, the entire znuD gene from
H44/76 was amplified with primers ZnuD-F and ZnuD-R. The
PCR product was cloned via pCRII-TOPO into the neisserial
replicative plasmid pEN11-pldA [40] using NdeI and AatII
restriction. In the resulting plasmid, pEN11-znuD, the znuD gene
is under control of an IPTG-inducible tandem lac/tac promoter.
To obtain a tonB knockout construct, DNA fragments upstream
and downstream of tonB (NMB1730) were amplified using primer
couples tonB-1/tonB-2 and tonB-3/tonB-4. The two fragments
were each cloned into pCRII-TOPO and then ligated together
using the AccI restriction site introduced via the primers and the
SpeI site present in the vector. The AccI site was used to insert the
chloramphenicol transacetylase gene obtained from pKD3 [41]
with primers P1 and P2. The resulting construct was amplified
using primers tonB-1 and tonB-4 and the PCR product was used
to transform N. meningitidis HB-1 to generate a tonB mutant. The
zur and znuA genes were knocked out following the same strategy.
The primer couples used to obtain the upstream and downstream
fragments were zur-1/zur-2 and zur-3/zur-4, and znuA-1/znuA-2
and znuA-3/znuA-4.
SDS-PAGE and Western blot analysis
Whole cell lysates were prepared from liquid cultures by
resuspending cell pellets in sample buffer. Proteins were separated
by routine SDS-PAGE or by semi-native SDS-PAGE, which
allows for analysis of outer membrane proteins in their native b-
barrel conformation [40]. After electrophoresis, the gels were
either stained with Coomassie brilliant blue or the proteins were
transferred to nitrocellulose membranes (Protran) using a wet
transfer system (Biorad) in 25 mM Tris-HCl, 192 mM glycine,
20% methanol. Membranes were blocked for 1 h in PBS
containing 0.1% Tween 20 and 0.5% Protifar (Nutricia). Blots
were incubated with antibodies in blocking buffer. Antibody
binding was detected by using peroxidase-conjugated goat anti-
rabbit or anti-human IgG secondary antibodies (Biosource) and
enhanced chemiluminescence detection (Pierce).
Isolation and refolding of recombinant ZnuD
E. coli BL21(DE3) (Invitrogen) containing pET11a-znuD was
grown in LB to an optical density at 600 nm of 0.6 after which
Table 1. Identity and similarity of ZnuD with its homologs.
Strain
Accession
number % identity % similarity
Moraxella catarrhalis AAU94646 41 58
Haemophilus parasuis YP_002474986 40 58
Mannheimia haemolytica AAK29743 46 63
Acinetobacter baumannii YP_001651932 41 61
Pasteurella multocida NP_246018 44 59
Bordetella pertussis NP_881648 35 51
Actinobacillus
pleuropneumoniae
YP_001651932 41 57
Neisseria gonorrhoeae YP_208276 96 97
doi:10.1371/journal.ppat.1000969.t001
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accumulated in inclusion bodies, which were isolated as described
[24]. The inclusion bodies were dissolved in 20 mM Tris-HCl,
100 mM glycine, 6 M urea (pH 8.3), and residual membranes
were removed by centrifugation for 1 h at 200,000 g. The protein
was then refolded into its native conformation by diluting this
stock solution 20-fold in refolding buffer containing 55 mM Tris-
HCl, 0.21 mM sodium chloride, 0.88 mM potassium chloride,
880 mM L-arginine and 0.5% 3-dimethyldodecylammoniopro-
pane-sulfonate (SB-12) (Fluka), pH 7.0. After refolding overnight,
the sample was dialyzed to 55 mM Tris-HCl, 0.21 mM sodium
chloride, 10 mM L-arginine, and 0.5% SB-12, pH 6.5. The
protein solution was filtered and stored at 4uC. Proper folding was
monitored by semi-native SDS-PAGE where the folded protein
has a higher electrophoretic mobility than the denatured protein.
Immunizations
Preparative SDS-PAGE was used to purify ZnuD from
inclusion body preparations. After staining the gel with Coomassie
brilliant blue, the band corresponding to ZnuD was electro-eluted
(Biorad) and used to immunize rabbits at Eurogentec.
To generate OMVs, strain CE1523 containing pEN11-znuD
was grown in the presence or absence of 1 mM IPTG. OMVs
were prepared by deoxycholate extraction and used to immunize
mice as described [10]. Sera from ten mice per group were
collected after 42 days and pooled.
Ethics statement
All animal experimentations were performed in compliance
with the current Belgian legislation related to the protection and
well-being of animals and the European directive 86/609/CEE
related to the protection of vertebrate animals used for
experimental or other scientific purposes. The experimental
protocols have been approved by GSK Biologicals Ethical
Commission for Animal Experimentation. All experimental
procedures were conducted at the GSK Belgium facilities, which
has a full AAALAC (Association for Assessment and Accreditation
of Laboratory Animal Care) accreditation since October 25th
2004.
RT-qPCR
RT-qPCR was performed using a 7900HT Fast Real-Time
PCR System and SYBR green master mix (Applied Biosystems).
Total RNA was isolated using Trizol (Invitrogen) and further
purified with nucleospin RNA II columns (Macherey-Nagel) and
treated with Turbo DNA-Free (Ambion) to yield DNA-free RNA.
cDNA was generated from 1 mg RNA using transcriptor High
fidelity cDNA synthesis kit (Roche). As a control, samples without
the reverse transcriptase were tested in parallel. PCRs were
performed in triplicate. The primers used are listed in Table S1. A
melting plot was performed to ensure that the signal originated
from the specific amplicon. Data analysis was performed using the
comparative cycle threshold method (Applied Biosystems) to
determine relative expression levels. The rmpM transcript was
used to normalize all data.
ICP-MS
Total zinc concentrations in RPMI medium were measured by
ICP-MS using an X Series 2 ICPMS (Thermo Scientific). Filtered
(0.22-mm) medium was acidified with HNO3 (suprapure, Merck)
prior to the measurements.
Zinc binding assay
In the PAR (Fluka) competition assay, the orange color of a
PAR/zinc complex changes towards yellow in the presence of a
protein that releases zinc from PAR. The assay was performed as
described [42] using 30 mM ZnSO4 and 20 mg OMVs. The assay
with the refolded protein as competitor was carried out in 55 mM
Tris-HCl, 0.21 mM sodium chloride, 10 mM L-arginine, and
0.5% SB-12, pH 6.5; in this assay, 50 mM PAR, 20 mM ZnSO4,
and 16 mg ZnuD were used.
Serum bactericidal assay
Wild type H44/76 carrying pEN11-znuD was inoculated from
overnight grown plates in TSB with 125 mM FeCl3 with or
without 1 mM IPTG in shaking flasks for 3 h at 37uC until an
optical density at 550 nm of 0.5 was reached. Serum bactericidal
assays were performed as described [10]. Bactericidal titers are
defined as the highest serum dilution yielding .50% killing.
Accession numbers
Accession numbers for the meningococcal proteins described in
this study in Genbank are: ZnuD (NMB0964), AAF62323; ZnuA
(NMB0586), AAF41014; ZnuB (NMB0587), AAF41015; ZnuC
(NMB0588), AAF41016; Zur (NMB1266), AAF41643; TonB
(NMB1730), AAF42075. Other accession numbers are provided
in Table 1.
Supporting Information
Figure S1 Alignment of meningococcal ZnuD homologs.
Aligned is the amino acid sequence of N. meningitidis strain
MC58 with those of strains 053422, FAM18 and Z2491, and the
carrier strains a14 and a153. The signal sequence, TonB box (Tb),
plug domain, surface-exposed loops and the transmembrane
domains (Tm) are marked above the sequence and the His- and
Asp-rich stretches are underlined.
Found at: doi:10.1371/journal.ppat.1000969.s001 (0.07 MB PDF)
Figure S2 Alignment of ZnuD homologs. Aligned are the amino
acid sequences of various pathogens. The histidine- and aspartic
acid-rich stretches are highlighted in grey.
Found at: doi:10.1371/journal.ppat.1000969.s002 (0.05 MB PDF)
Table S1 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000969.s003 (0.05 MB
DOC)
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